The present study was designed to assess the effect of DMSO on necrosis of the distal portion of random skin flaps.
ANIMALS AND METHODS
A total of 28 Wistar EPM-1 adult male rats, weighing from 185 to 230 g, were randomly assigned to two groups. Animals in group 1 (control, n=14) received distilled water and those in group 2 (n=14) received DMSO 2 mL/kg/day (99.9%) by gastric lavage. The first dose was administered just before surgery.
Animals were anesthetized with sodium pentobarbital (40 mg/kg) intraperitoneally and then depilated. A random skin flap was elevated, with a cranial base, measuring 10x4 cm on the back of the animals (8, 9) (Figure 1) . A plastic barrier with the same dimensions was placed between the flap and its bed (10) (11) (12) (Figure 2 ) and was closed with simple nylon 4-0 stitches ( Figure 3 ).
Rats in group 1 received distilled water and those in group 2 received DMSO in daily doses from the first to the seventh day after the operation. On the seventh day postoperation, the distal necrotic area of the flaps (Figure 4 ) was checked via the paper template method (11) . Blood samples from the portal vein of each animal were collected by laparotomy and centrifuged to determine the concentration of MDA in the serum ( Figure 5 ).
Two resections of skin tissue samples, each measuring 1x1 cm, were performed for each animal. One sample was obtained in an area with normal tissue in the upper left portion of the back, at a standard distance of 1 cm from the flap suture (sample A); another sample with the same measurements was obtained within the flap, in the transition area between viable tissue and necrotic tissue, in the region to the left of this transition (sample B) ( Figure 6 ).
Skin samples were added to potassium chloride (1.15%), submitted to homogenization and centrifuged, and the floating result was collected to determine the concentration of MDA. All MDA calculations were done using the thiobarbituric acid method modified by Percário et al (3) .
RESULTS
The necrotic area in group 1 ranged between 51.14% and 76.67% (average 65.70%), while that in group 2 ranged between 17.86% and 42.53% (average 31.37%). MDA serum concentrations in group 1 ranged between 494 and 1027 ng/ mL (average 680 ng/mL), and between 288 and 712 ng/mL (average 475 ng/mL) in group 2. The MDA concentration in normal skin samples ranged from 1255 to 3345 ng/mL (average 2038 ng/mL) in group 1 and from 618 to 2031 ng/mL (average 1006 ng/mL) in group 2. The proportion of MDA in the viable to necrotic transition skin samples ranged from 417 to 1915 (average 1235 ng/mL) in group 1 and from 301 to 904 (average 516 ng/mL) in group 2. The Mann-Whitney test for independent groups showed that the differences were statistically significant (Tables 1-4) .
DISCUSSION
The presence of ischemia represents a situation of risk and is part of the daily life of the plastic surgeon, whether the cause be traumatic (lacerations and avulsions) or therapeutic (grafts, flaps or microsurgical transplants). The study of ischemic phenomena and their prevention and treatment can increase the percentage of good results of treatment under unfavourable conditions or can reduce the index of complications in these cases.
The actions of oxygen, ROTS and antioxidant substances have been studied in relation to a series of pathologies and to ageing. Each antioxidant has a unique effect on the various levels of cellular defence. In each case, it must be estimated whether free radicals are being generated in the intracellular and/or extracellular environment. Also, the mechanism of antioxidant action differentiates them; mechanisms can be enzymatic or nonenzymatic, hydrophobic or hydrophillic (13) . Thus, for an antioxidant to be efficient, it must not only act against the radicals by a compatible mechanism, but also function in the same setting as the radical.
The loss of a skin flap can be attributed to both extrinsic Effect of DMSO on skin flap necrosis in rats and intrinsic factors. Extrinsic factors include systemic (infection, arteriosclerosis, hypotension or malnutrition) and local (compression, tension or thrombosis of anastomosis) alterations, but inadequate blood flow is the only intrinsic factor, as demonstrated by Kerrigan (14) .
In our study we used a model of skin flaps that develops ischemia in the distal portion, with measurements of 10x4 cm (9) . Plastic film was interposed between the flap and the bed, impeding the revascularization of the flap through the bed veins, thus guaranteeing homogeneous conditions of ischemia and necrosis (10, 15) . The paper template (11) was selected to evaluate the percentage of necrotic area because it is simple and quick, requiring only transparent paper and a precise scale.
DMSO is a pharmacological agent used as an antiphlogistic (inhibiting neutrophils and the biosynthesis of prostaglandins) and an antioxidant (acting on hydroxyl radicals) (16) (17) (18) (19) (20) (21) (22) . It has been demonstrated that DMSO suppresses the bactericide activity of the neutrophils (7); thus, its antiphlogistic effect is a result of its own antioxidant properties and not of an independent action of this drug.
There have been a great number of studies concerning the use of DMSO in various clinical and experimental applications, using different doses, concentrations and methods of administration (16, 18, (20) (21) (22) (23) (24) . According to Rubin (18) , DMSO is relatively nontoxic and is well tolerated in high doses by animals.
The only paper we found describing the use of DMSO in flaps is an experimental study by Adamson et al (23) , in which DMSO was administered topically. Those authors found a significant reduction in the necrotic area, but they did not correlate the effect with the drug's antioxidant action.
Because there were no references to experimental studies of the use of DMSO in flaps, both pedicled and microsurgical, administered through intragastric lavage, the present study was elaborated to investigate the action of this drug in known and reproducible conditions of ischemia in random skin flaps in rats. DMSO (99.9%) was used at a dose of 2 mL/kg/day because in studies in the literature, the dosage in rats was between 0.5 and 2.0 mL/kg/day for the same concentration and method of application (18, 19, 25) .
In group 1 rats, the average percentage of necrotic area was 65.7%; in group 2 it was 31.37%. The use of DMSO was effective according to the model used, reducing the necrotic area of the distal portion of the flap in group 2 in relation to group 1.
To verify the reduction in necrotic area that occurred due to the antioxidant effect of DMSO, we tested the concentration of MDA in serum and the skin. MDA was measured on two skin samples in each animal in both groups, using normal skin and viable to necrotic transition skin.
With the ischemia and necrosis provoked in this study, there was a liberation of products and subproducts of lipid peroxidation into the circulation; as a result, it was expected that the levels of MDA in the serum of the animals that received DMSO would be lower than those in the control group. The MDA values in the serum of group 2 animals were significantly lower than those of group 1. In group 1, MDA ranged from 494 to 1027 ng/mL (average 680 ng/mL) and in group 2, from 288 to 712 ng/mL (average 475 ng/mL).
In the samples of normal skin, the values of MDA were significantly lower in group 2 (average 1006 ng/mL) than those in group 1 (average 2038 ng/mL necrotic transition area were lower in group 2 (516 ng/mL) than in group 1 (1236 ng/mL). In both groups 1 and 2, we expected lower values of MDA concentration in skin from the viable to necrotic transition region compared with the samples of normal skin; we also expected that group 2's values would be lower than those from group 1. The fact that the concentration of MDA in the samples of normal skin was higher than that in the skin from the viable to necrotic transition region may appear contradictory but must have occurred because in each sample of transition skin there is a large percentage of completely necrotic tissue, where there is no longer a way to measure the concentration of MDA.
After analyzing the results of MDA measurement in serum versus in skin samples, it is apparent that despite the difference between the groups concerning the absolute values found in the serum -which were not as pronounced as those in the skin sample measurements -we can use serum MDA measurement as a way of estimating the efficiency of the dose of DMSO used in other experimental models that are similar to the one used in this study. DMSO 2 mL/kg/day was effective in the reduction of necrosis. In both the serum and skin samples, MDA was significantly lower in the group treated with DMSO (group 2) than in controls (group 1). Thus, it can be inferred that the action of DMSO as an antioxidant was the mechanism responsible for the results observed in group 2. This study demonstrated the role of the hydroxyl radical in the ischemia of skin flaps in rats and the improvement of the results using an antioxidant that acts specifically on these radicals. It is important to evaluate whether other antioxidants in addition to DMSO act on the hydroxyl radical and are efficient under the same ischemia conditions. In addition, it is necessary to investigate whether there is participation from other radicals in the ischemia in skin flaps, as well as in other plastic surgery procedures, and to determine the antioxidants that are most efficient in the corresponding situations.
In the future, the determination of the ideal antioxidants for clinical use will, together with the use of substances that increase arterial flow to the flaps, broaden the therapeutic resources available to plastic surgeons, contributing to a reduction in ischemic complications in both emergency and elective situations.
